Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bio-Path Holdings, Inc. - Common Stock
(NQ:
BPTH
)
0.2100
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bio-Path Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Earnings Scheduled For May 17, 2022
↗
May 17, 2022
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter.
Via
Benzinga
A Preview Of Bio-Path Holdings's Earnings
↗
May 16, 2022
Bio-Path Holdings (NASDAQ:BPTH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Bio-Path...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 13, 2022
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
April 13, 2022
Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Why Bio-Path Holdings Shares Are Rising After Hours
↗
April 12, 2022
Bio-Path Holdings Inc (NASDAQ: BPTH) shares are trading higher in Tuesday's after-hours session following the company's BP1003 data presentation at the 2022 American Association for Cancer Research...
Via
Benzinga
The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China
↗
March 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In...
Via
Benzinga
Bio-Path Holdings: Q4 Earnings Insights
↗
March 11, 2022
Bio-Path Holdings (NASDAQ:BPTH) reported its Q4 earnings results on Friday, March 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For March 11, 2022
↗
March 11, 2022
Companies Reporting Before The Bell • The Real Good Food (NASDAQ:RGF) is estimated to report quarterly loss at $0.19 per share on revenue of $25.29 million. •...
Via
Benzinga
Earnings Preview: Bio-Path Holdings
↗
March 10, 2022
Bio-Path Holdings (NASDAQ:BPTH) is set to give its latest quarterly earnings report on Friday, 2022-03-11. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
40 Stocks Moving In Monday's Mid-Day Session
↗
December 13, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....
Via
Benzinga
58 Biggest Movers From Yesterday
↗
December 14, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...
Via
Benzinga
22 Stocks Moving in Monday's Pre-Market Session
↗
December 13, 2021
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday. Foghorn Therapeutics Inc. (NASDAQ: FHTX) rose...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 08, 2021
Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7...
Via
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
↗
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
November 19, 2021
Gainers CASI Pharmaceuticals (NASDAQ:CASI
Via
Benzinga
Earnings Scheduled For November 12, 2021
↗
November 12, 2021
Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 27, 2021
Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
September 02, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 31, 2021
Gainers Sonnet BioTherapeutics (NASDAQ:SONN
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 25, 2021
Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell Bioscience's stock is trading at a volume of 8...
Via
Benzinga
60 Biggest Movers From Yesterday
↗
August 25, 2021
Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 24, 2021
Gainers Regencell Bioscience (NASDAQ:RGC)...
Via
Benzinga
BPTH Stock: The Good News That Has BioPath Investors Smiling Today
↗
August 24, 2021
BioPath (BPTH) stock is soaring higher on Tuesday after revealing an update from the FDA on its IND application for BP1002.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 24, 2021
Gainers Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As of 12:30 EST, Triple-S Management's stock is...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide
↗
August 24, 2021
Midway through trading Tuesday, the Dow traded up 0.09% to 35,368.20 while the NASDAQ rose 0.40% to 15,001.95. The S&P also rose, gaining 0.14% to 4,486.01. The U.S. has the...
Via
Benzinga
Topics
Stocks
38 Stocks Moving In Tuesday's Mid-Day Session
↗
August 24, 2021
Gainers Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc,...
Via
Benzinga
BPTH Stock: Why Little-Known Bio-Path Holding Just Popped More Than 20%
↗
August 24, 2021
BPTH stock is shooting up this morning as the company reveals a new plan for evaluating the effectiveness of one of its drugs.
Via
InvestorPlace
Why Bio-Path Holdings Shares Are Surging Higher Today
↗
August 24, 2021
Bio-Path Holdings Inc (NASDAQ: BPTH) is surging higher Tuesday after the company announced the U.S Food and Drug Administration reviewed and cleared its ...
Via
Benzinga
Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates
↗
August 24, 2021
Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also rose, gaining 0.22% to 4,489.23. The U.S. has...
Via
Benzinga
Topics
Stocks
Why Bio-Path Shares Are Moving Higher In Premarket Tuesday?
↗
August 24, 2021
The FDA has signed off Bio-Path Holdings Inc's (NASDAQ: BPTH) Investigational New Drug (IND) application for BP1002 in refractory/relapsed acute myeloid...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.